Skip directly to content

As TAG marks its 25th Anniversary this year, we were honored to host our annual event, the Research in Action Awards, on Thursday, November 16, 2017, at SLATE in New York City. This was a truly meaningful evening, celebrating a quarter century of activism and progress promoting research, prevention, and treatment critical to ending the global and domestic HIV/AIDS epidemic.

Download the PDF of the Event Journal

DETAILS
The 2017 Research in Action Awards were co-chaired by Robert Monteleone and Sally Morrison. Longtime friends

New York, NY, July 18, 2017 – Treatment Action Group (TAG) announces the launch of its annual research and development landscape analysis: The Pipeline Report: Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development.
 Pipeline Report_2017_Cover
Released in advance of the 9th IAS Conference on HIV Science convening next week in Paris, our 2017 report continues to demonstrate the significant yields of drugs and biologics research and the advancement of breakthrough technologies that aim to detect, prevent, treat or cure HIV, tuberculosis (TB) and

TAG’s Annual Pipeline Report: Promising New HIV, TB & HCV Drugs and Diagnostics But Political Will Slows Progress

Released in advance of the 9th IAS Conference on HIV Science convening next week in Paris, our 2017 report continues to demonstrate the significant yields of drugs and biologics research and the advancement of breakthrough technologies that detect, prevent, treat or cure HIV, tuberculosis (TB) and hepatitis C virus (HCV).

Tags: 
The newly-formed Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) aims to advise the Secretary of Health and Human Services (HHS) on gaps in research and knowledge to inform safe and effective therapies for pregnant and postpartum women. PRGLAC is tasked with identifying these gaps and will report its findings back to the Secretary. PRGLAC is scheduled to meet in August for their first meeting. 
 
In response, TAG is submitting a community public comment (below) on how the federal government can strategically address critical gaps in research on the safe and

2017 Pipeline Report

July 5, 2017

HIV, TB, and HCV

Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development

Written by Mike Frick, Annette Gaudino, Mark Harrington, Tim Horn, Richard Jefferys, Jeremiah Johnson, Erica Lessem, Marcus Low, and Lindsay McKenna

In this year's report:

Introduction and Executive Summary
Mark Harrington

The Antiretroviral Pipeline
Tim Horn

Preventive Technologies: Antiretroviral and Vaccine Development

Sign-on letter to Pfizer urging an immediate response to the nationwide shortage of pencillin G benzathine, the standard treatment for primary and secondary syphyilis.

July 21, 2017

Ian C. Read
c/o Margaret M. Madden
Senior Vice President and Corporate Secretary
Chief Governance Counsel at Pfizer Inc.
235 East 42nd Street, 
New York, New York 10017

Dear Mr. Read,

We the undersigned urge Pfizer to adequately and promptly address the penicillin G benzathine (Bicillin-LA) shortage to ensure normal quantities in the United States.

Fogarty Social Media Advocacy Toolkit

June 14, 2017 ​This week on June 15, Health and Human Services (HHS) Secretary Tom Price will sit before the Senate Subcommittee on Labor, Health and Human Services, Education and Related Agencies (LHHS) to defend the President’s fiscal year 2018 (FY18) budget proposal. 

FY18 funding proposal still includes the complete elimination of the Fogarty International Center, among many destructive cuts to the budget of the National Institutes of Health (NIH). 

Join American Society for Tropical Medicine and Hygiene (ASTMH), HIV Medicine Association (HIVMA),

Engaging Your Policy Makers Ahead of the TB Ministerial Conference

Original air date: June 6, 2017  - In November, Ministers of Health and Finance from 56 of the most high burden TB countries will gather in Moscow for the first ever Ministerial Conference on TB. This webinar provided participants with specific skills on how to engage policymakers ahead of this conference and identify opportunities for civil society engagement. 
 
Speakers covered:
  • how to identify influential policymakers and engage them on TB,
  • what messages resonate with policymakers,
  • how to engage Parliamentarians,
  • identified opportunities for coordinated civil society engagement ahead of
Original air date: June 6, 2017  - In November, Ministers of Health and Finance from 56 of the most high burden TB countries will gather in Moscow for the first ever Ministerial Conference on TB. This webinar provided participants with specific skills on how to engage policymakers ahead of this conference and identify opportunities for civil society engagement. 
 
Speakers covered:
  • how to identify influential policymakers and engage them on TB,
  • what messages resonate with policymakers,
  • how to engage Parliamentarians,
  • identified opportunities for coordinated civil society engagement ahead of

TAG’s strong financial health and commitment to accountability and transparency have earned it a 4-star rating from Charity Navigator, America’s largest independent charity evaluator.

This is the second consecutive year that TAG has earned this top distinction.

Since 2002, using objective analysis, Charity Navigator has awarded only the most fiscally responsible organizations a 4-star rating. In 2011, Charity Navigator added 17 metrics, focused on governance and ethical practices as well as measures of openness, to its ratings methodology.

Pages